About Us

GeneTether is an early stage biotechnology company developing improved gene editing technologies using Crispr/Cas, TALEN, and Zinc-Finger nucleases for human therapeutic applications. We are engineering an approach that gives the DNA repair-templates the same “address” as the nuclease-initiated DNA strand breaks, ensuring their presence when needed for gene editing. This could improve gene editing efficiencies while reducing unintended unwanted DNA damage and mutation.